Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

"IceCure’s cryoablation system for breast cancer treatment gains FDA panel support" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this ...

Insurance coverage for breast cancer screening, diagnosis, and treatment is critical to getting access to healthcare for this ...

Researchers at the Markey Cancer Center have made an important discovery that could lead to new treatments for ...

RIYADH, Saudi Arabia, Nov. 10, 2024 (GLOBE NEWSWIRE) -- (KFSHRC) announced a significant advancement in stem cell science, ...

Researcher creates a groundbreaking genetic model for breast cancer, offering new insights and potential advances in ...

Yale study reveals cultural influences in breast cancer surgery decisions, focusing on challenges faced by women of color post-mastectomy.

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients.

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

(RTTNews) - IceCure Medical Ltd. (ICCM), Friday announced that the U.S. Food and Drug Administration's Advisory panel has voted in favor of the company's ProSense technology intended for early-stage ...

In this on-demand webinar series, CURE partnered with City of Hope to discuss how patients with breast cancer can best ...